All news

Boundless Bio director, 10% owner Kevin Tang buys $349k in shares

Alpha Vantage · Investing.com India · · AI-summarised by FinFlash

Kevin Tang, a director and 10% owner of Boundless Bio, Inc. (BOLD), recently purchased approximately $349,592 worth of common stock through entities he controls in October 2026. These transactions occurred between October 16 and October 20, at prices ranging from $2.33 to $2.37 per share. Following these purchases, Mr. Tang's entities beneficially own 2,990,109 shares of Boundless Bio.

Read original source

BOLD company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.